{"brief_title": "A Study of Cabergoline for the Treatment of Cocaine Dependence - 1", "brief_summary": "The purpose of this study is to assess cabergoline for the Treatment of Cocaine Dependence", "detailed_description": "To assess the efficacy and safety of cabergoline in reducing cocaine use in subjects with cocaine dependence. This is a DB, placebo-controlled, parallel group design study where subjects will receive either .5mg cabergoline or placebo for 12 weeks with a 4 week follow-up.", "condition": ["Cocaine-Related Disorders", "Substance-Related Disorders"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Cabergoline", "Placebo"], "arm_group_label": ["Cabergoline", "Placebo"], "other_name": ["Dostinex"], "description": ["sugar pill manufactured to mimic cabergoline 05mg tablet"], "criteria": "Inclusion Criteria: Must have a DSM-4 criteria for cocaine dependence; be seeking treatment for cocaine dependence; have the ability to understand and provide written informed consent; females of child-bearing potential using proper method of birth control. Exclusion Criteria: Additional criteria available during screening at the site.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "99 Years", "healthy_volunteers": "No", "mesh_term": ["Disease", "Cocaine-Related Disorders", "Substance-Related Disorders", "Cabergoline", "Cocaine"], "id": "NCT00033111"}